Table 3 Proportion of patient eligible for MR-HIFU treatment
Inclusion criteria | Proportion (%) |
|---|---|
Tumour ≤ 3 cm | 78.6 |
No lymph node metastasis | 65.0 |
No lobular subtype | 90.2 |
No EIC | 84.6 |
No previous surgery | 91.3 |
No renal insufficiency | 97.3 |
Not multifocal | 82.0 |
No BRCA mutation | 97.4 |
Tumour reachable | 66.3 |
Distance to skin ≥ 1 cm | 65.0 |
Eligible patientsa | 11.9 |